Mayo Clinic
Backing AI companies from USA
$500M
Awaira Score
out of 100
AI, Health, Biotech is where Mayo Clinic places their bets. They typically invest at the Early Stage stage. With $500M under management, they've got the firepower to write big checks. They've backed 1 AI companies so far.
Investment Strategy Analysis
Mayo Clinic deploys capital from USA with a clear mandate in AI, Health, Biotech. The firm primarily targets Early Stage opportunities, positioning it to capture value at a specific inflection point in company growth. Managing $500M across 1 known investments suggests a concentrated, high-conviction approach to AI investing. The firm holds a solid position among tracked AI investors, with room to grow its footprint in the ecosystem.
Score
60/100
AUM
$500M
Portfolio Size
1
Founded
1889
Stage Focus
Early Stage
Country
🇺🇸 USA
Assets Under Mgmt
$500M
Total capital managed
Portfolio Companies
1
Companies backed
Stage Focus
Early Stage
Preferred investment stage
Focus Areas
About Mayo Clinic
Mayo Clinic is a early-stage venture capital firm founded in 1889, headquartered in USA, managing approximately $500M in assets under management. The firm concentrates on AI, Health, Biotech, deploying capital primarily at the early stage level. Notable AI portfolio companies include PathAI. Mayo Clinic has participated in 1 funding round tracked by Awaira, deploying capital across AI, Health, Biotech sectors. The firm's investment strategy emphasizes AI applications in healthcare and life sciences. Awaira assigns Mayo Clinic an investor score of 60/100 based on portfolio strength, AI sector exposure, and market activity. The firm investment thesis centers on identifying AI companies that demonstrate strong technical moats, clear paths to revenue, and potential for category leadership within their respective segments. Mayo Clinic evaluates opportunities based on team quality, market timing, technology differentiation, and capital efficiency. Portfolio companies including PathAI reflect the firm emphasis on backing founders who combine deep technical expertise with commercial execution capability.
Founded: 1889
Investment Focus
Portfolio Companies(1)
Portfolio Metrics
Companies
1
Categories
1
Top Sector
AI Healthcare (1)
Avg Score
62/100
Frequently Co-Invests With
Notable Deal
Mayo Clinic is a early-stage venture capital firm founded in 1889, headquartered in USA, managing approximately $500M in assets under management. The firm concentrates on AI, Health, Biotech, deploying capital primarily at the early stage level. Notable AI portfolio companies include PathAI. Mayo Clinic has participated in 1 funding round tracked by Awaira, deploying capital across AI, Health, Biotech sectors. The firm's investment strategy emphasizes AI applications in healthcare and life sciences. Awaira assigns Mayo Clinic an investor score of 60/100 based on portfolio strength, AI sector exposure, and market activity. The firm investment thesis centers on identifying AI companies that demonstrate strong technical moats, clear paths to revenue, and potential for category leadership within their respective segments. Mayo Clinic evaluates opportunities based on team quality, market timing, technology differentiation, and capital efficiency. Portfolio companies including PathAI reflect the firm emphasis on backing founders who combine deep technical expertise with commercial execution capability.
Investment Track Record
AUM
$500M
Notable Deal
Mayo Clinic is a early-stage venture capital firm ...
Founded
1889
Stage
Early Stage
Mayo Clinic manages $500M, deploying capital with conviction into AI opportunities that match their thesis.
Portfolio News
Explore More